📣 VC round data is live. Check it out!
- Public Comps
- Shimadzu
Shimadzu Valuation Multiples
Discover Shimadzu's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Shenzhen Kedali Industry, Sensata Technologies, Karman Space & Defense, Firefly Aerospace and more.
Shimadzu Overview
About Shimadzu
Shimadzu Corp is a Japan-based company engaged in the manufacture of precision instruments, measuring equipment, and medical devices. The firm operates in four segments: Aviation Equipment, Industrial Equipment, Measuring Equipment, Medical Equipment, and Others. It generates the majority of its revenue from the Measuring Equipment segment, which is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems, and others.
Founded
1875
HQ

Employees
16.2K
Website
Financials (LTM)
EV
$6B
Valuation Multiples
Start free trialShimadzu Financials
Shimadzu reported last 12-month revenue of $4B and EBITDA of $604M.
In the same LTM period, Shimadzu generated $2B in gross profit, $604M in EBITDA, and $379M in net income.
Revenue (LTM)
Shimadzu P&L
In the most recent fiscal year, Shimadzu reported revenue of $3B and EBITDA of $577M.
Shimadzu is profitable as of last fiscal year, with gross margin of 43%, EBITDA margin of 17%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Shimadzu Stock Performance
Shimadzu has current market cap of $7B, and enterprise value of $6B.
Market Cap Evolution
Shimadzu's stock price is $24.75.
Shimadzu share price increased by 4.4% in the last 30 days, and by 10.1% in the last year.
Shimadzu has an EPS (earnings per share) of $1.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $7B | 4.4% | 4.4% | 6.5% | 10.1% | $1.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShimadzu Valuation Multiples
Shimadzu trades at 1.7x EV/Revenue multiple, and 10.2x EV/EBITDA.
EV / Revenue (LTM)
Shimadzu Financial Valuation Multiples
As of June 2, 2026, Shimadzu has market cap of $7B and EV of $6B.
Shimadzu has a P/E ratio of 18.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shimadzu Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Shimadzu Margins & Growth Rates
Shimadzu grew revenue by 5% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, Shimadzu reported gross margin of 43%, EBITDA margin of 17%, and net margin of 10%.
Shimadzu Margins
Shimadzu Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Shimadzu Operational KPIs
Shimadzu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Shimadzu's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shimadzu's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Shimadzu Competitors
Shimadzu competitors include Shenzhen Kedali Industry, Sensata Technologies, Karman Space & Defense, Firefly Aerospace, Horiba, Spirax Group, Konecranes, Hangzhou First Applied, Wuhan Jingce and Hexcel.
Most Shimadzu public comparables operate across Medical Devices, Test & Measurement, Aircraft & Space Systems, Industrial Parts, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.0x | 2.7x | 14.9x | 13.6x | |||
| 2.5x | 2.5x | 11.0x | 10.8x | |||
| 16.8x | 13.6x | 54.4x | 45.5x | |||
| 42.3x | 24.5x | (32.3x) | (29.3x) | |||
| 3.0x | 2.9x | 14.8x | 13.9x | |||
| 3.4x | 3.4x | 14.6x | 14.1x | |||
| 1.5x | 1.5x | 9.1x | 9.1x | |||
| 2.6x | 2.5x | 29.0x | 23.2x | |||
This data is available for Pro users. Sign up to see all Shimadzu competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Shimadzu
Shimadzu has acquired 2 companies to date.
Last acquisition by Shimadzu was on December 25th 2025. Shimadzu acquired TESCAN for $678M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Shimadzu
| Description | TESCAN is a Brno-headquartered supplier of scanning electron microscopes and focused ion beam systems for materials science and life sciences. It manufactures SEMs with resolutions down to 0.4 nm, including environmental and plasma models for semiconductors, geology, and biology. TESCAN develops correlative microscopy software and detectors. Founded in 1992, the Czech company serves research institutes in 90 countries with subsidiaries in the US, China, and Germany. | Alsachim SAS is a Strasbourg-headquartered contract research organization offering chemistry development services worldwide. The company provides custom synthesis, analytical method development, and scale-up production for pharmaceutical and fine chemical clients. |
| HQ Country | ||
| HQ City | Brno | Strasbourg |
| Deal Date | 25 Dec 2025 | 21 Jun 2017 |
| Valuation | $678M | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Shimadzu acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by Shimadzu
Shimadzu has invested in 4 companies to date.
Latest investment by Shimadzu was on April 14th 2025. Shimadzu invested in RLWRLD in their $15M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by Shimadzu
| Description | RLWRLD is an AI robotics company developing foundation models for physical AI, enabling autonomous robot operations in unstructured real-world settings. Their robotics foundation models process sensor data for navigation, manipulation, and task execution. | - | MCBI is a Tokyo-based bioinformatics company focused on molecular and clinical data analysis for pharmaceutical research. The firm provides genomic sequencing interpretation, protein modeling, and pathway simulations using proprietary algorithms. Serving Japanese biotech firms and academic institutions, MCBI integrates next-generation sequencing data with clinical records to accelerate drug discovery and personalized medicine initiatives in oncology and rare diseases. | iPS PORTAL is a Kobe, Japan-based biotechnology service provider specializing in contract testing and quality assurance for induced pluripotent stem (iPS) cells to support research and therapeutic development. The company operates under the Center for iPS Cell Research Application at Kyoto University, offering assays for pluripotency, genetic stability, and differentiation potential. iPS PORTAL facilitates global adoption of iPS technology through standardized testing protocols compliant with Japanese and international regulations, serving academic institutions, pharmaceutical companies, and regenerative medicine firms across Asia and Europe. |
| HQ Country | ||||
| HQ City | Seoul | - | Tokyo | Kyoto |
| Deal Date | 14 Apr 2025 | 23 Jan 2025 | 22 Aug 2017 | 27 Feb 2015 |
| Round | Seed | Series A | Strategic investment | Series A |
| Raised | $15M | $12M | $5M | $12M |
| Investors | Amber Enterprises India; ANA Holdings; Global Brain Corporation; Hashed; KDDI; LG Electronics; Mirae Asset Venture Investment; Mitsui Chemicals; PKSHA Technology; Shimadzu; SK Telecom | AVP; Chiyoda; Deloitte Ventures; Glasswing Ventures; Global Brain Corporation; Shimadzu | Shimadzu; Taiyo Life Insurance | Ajinomoto; Chugai Pharma; Daiichi Jitsugyo; Daiwa Securities Group; Eisai Co.; Horiba; SCREEN Holdings Co.; Shimadzu; Shin Nippon Biomedical; SMBC Venture Capital; Sumitomo Mitsui Trust Bank; Sysmex |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Shimadzu investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shimadzu
| When was Shimadzu founded? | Shimadzu was founded in 1875. |
| Where is Shimadzu headquartered? | Shimadzu is headquartered in Japan. |
| How many employees does Shimadzu have? | As of today, Shimadzu has over 16K employees. |
| Who is the CEO of Shimadzu? | Shimadzu's CEO is Yasunori Yamamoto. |
| Is Shimadzu publicly listed? | Yes, Shimadzu is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Shimadzu? | Shimadzu trades under 7701 ticker. |
| When did Shimadzu go public? | Shimadzu went public in 1949. |
| Who are competitors of Shimadzu? | Shimadzu main competitors include Shenzhen Kedali Industry, Sensata Technologies, Karman Space & Defense, Firefly Aerospace, Horiba, Spirax Group, Konecranes, Hangzhou First Applied, Wuhan Jingce, Hexcel. |
| What is the current market cap of Shimadzu? | Shimadzu's current market cap is $7B. |
| What is the current revenue of Shimadzu? | Shimadzu's last 12 months revenue is $4B. |
| What is the current revenue growth of Shimadzu? | Shimadzu revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Shimadzu? | Current revenue multiple of Shimadzu is 1.7x. |
| What is the current EBITDA of Shimadzu? | Shimadzu's last 12 months EBITDA is $604M. |
| What is Shimadzu's EBITDA margin? | Shimadzu's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Shimadzu? | Current EBITDA multiple of Shimadzu is 10.2x. |
| What is the current FCF of Shimadzu? | Shimadzu's last 12 months FCF is $201M. |
| What is Shimadzu's FCF margin? | Shimadzu's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Shimadzu? | Current FCF multiple of Shimadzu is 30.6x. |
| How many companies Shimadzu has acquired to date? | As of June 2026, Shimadzu has acquired 2 companies. |
| What was the largest acquisition by Shimadzu? | $678M acquisition of TESCAN on 25th December 2025 was the largest M&A Shimadzu has done to date. |
| What companies Shimadzu acquired? | Shimadzu acquired TESCAN and Alsachim SAS. |
| In how many companies Shimadzu has invested to date? | As of June 2026, Shimadzu has invested in 4 companies. |
| What was the last Shimadzu investment? | On 14th April 2025 Shimadzu invested in RLWRLD, participating in a $15M Seed round, alongside Amber Enterprises India, ANA Holdings, Global Brain Corporation, Hashed, KDDI, LG Electronics, Mirae Asset Venture Investment, Mitsui Chemicals, PKSHA Technology, and SK Telecom. |
| In what companies Shimadzu invested in? | Shimadzu invested in RLWRLD, IPS Portal, Basetwo AI, and MCBI. |
See public comps similar to Shimadzu
Lists including Shimadzu
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




